nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Carmustine—lymphatic system cancer	0.258	0.471	CbGbCtD
Rifabutin—CYP3A4—Cytarabine—lymphatic system cancer	0.0921	0.168	CbGbCtD
Rifabutin—CYP3A4—Teniposide—lymphatic system cancer	0.0907	0.166	CbGbCtD
Rifabutin—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0634	0.116	CbGbCtD
Rifabutin—CYP3A4—Vincristine—lymphatic system cancer	0.0437	0.0798	CbGbCtD
Rifabutin—Pathogen resistance—Mitoxantrone—lymphatic system cancer	0.03	0.0682	CcSEcCtD
Rifabutin—Cross resistance—Mitoxantrone—lymphatic system cancer	0.03	0.0682	CcSEcCtD
Rifabutin—Burkitt's lymphoma—Methotrexate—lymphatic system cancer	0.0294	0.0669	CcSEcCtD
Rifabutin—Neutrophil count decreased—Fludarabine—lymphatic system cancer	0.0182	0.0414	CcSEcCtD
Rifabutin—Lymphopenia—Mechlorethamine—lymphatic system cancer	0.0143	0.0326	CcSEcCtD
Rifabutin—HSP90AA1—Gemcitabine—Cytarabine—lymphatic system cancer	0.013	1	CbGdCrCtD
Rifabutin—Urine color abnormal—Mitoxantrone—lymphatic system cancer	0.012	0.0273	CcSEcCtD
Rifabutin—Chromaturia—Mitoxantrone—lymphatic system cancer	0.00791	0.018	CcSEcCtD
Rifabutin—White blood cell count decreased—Mitoxantrone—lymphatic system cancer	0.00568	0.0129	CcSEcCtD
Rifabutin—Platelet count decreased—Mitoxantrone—lymphatic system cancer	0.00475	0.0108	CcSEcCtD
Rifabutin—Aphasia—Carmustine—lymphatic system cancer	0.00468	0.0107	CcSEcCtD
Rifabutin—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.00436	0.00993	CcSEcCtD
Rifabutin—Jaundice—Mechlorethamine—lymphatic system cancer	0.00399	0.00909	CcSEcCtD
Rifabutin—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00382	0.0087	CcSEcCtD
Rifabutin—Bronchospasm—Teniposide—lymphatic system cancer	0.00333	0.00758	CcSEcCtD
Rifabutin—Pancytopenia—Teniposide—lymphatic system cancer	0.00322	0.00732	CcSEcCtD
Rifabutin—Neutropenia—Teniposide—lymphatic system cancer	0.00317	0.00721	CcSEcCtD
Rifabutin—Bacterial infection—Methotrexate—lymphatic system cancer	0.00305	0.00693	CcSEcCtD
Rifabutin—Blood bilirubin increased—Mitoxantrone—lymphatic system cancer	0.00299	0.00679	CcSEcCtD
Rifabutin—Hepatic enzyme increased—Mitoxantrone—lymphatic system cancer	0.00299	0.00679	CcSEcCtD
Rifabutin—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00287	0.00652	CcSEcCtD
Rifabutin—Pancytopenia—Fludarabine—lymphatic system cancer	0.00283	0.00643	CcSEcCtD
Rifabutin—Neutropenia—Fludarabine—lymphatic system cancer	0.00278	0.00634	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00271	0.00616	CcSEcCtD
Rifabutin—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00256	0.00582	CcSEcCtD
Rifabutin—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00254	0.00578	CcSEcCtD
Rifabutin—Anorexia—Mechlorethamine—lymphatic system cancer	0.00249	0.00567	CcSEcCtD
Rifabutin—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00227	0.00517	CcSEcCtD
Rifabutin—Anaemia—Teniposide—lymphatic system cancer	0.00218	0.00497	CcSEcCtD
Rifabutin—Aphasia—Methotrexate—lymphatic system cancer	0.00217	0.00494	CcSEcCtD
Rifabutin—Bronchospasm—Bleomycin—lymphatic system cancer	0.00215	0.00489	CcSEcCtD
Rifabutin—Leukopenia—Teniposide—lymphatic system cancer	0.00211	0.00481	CcSEcCtD
Rifabutin—Pancytopenia—Bleomycin—lymphatic system cancer	0.00207	0.00472	CcSEcCtD
Rifabutin—Chest pain—Teniposide—lymphatic system cancer	0.00201	0.00457	CcSEcCtD
Rifabutin—Confusional state—Teniposide—lymphatic system cancer	0.00194	0.00442	CcSEcCtD
Rifabutin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00193	0.00438	CcSEcCtD
Rifabutin—Anaemia—Fludarabine—lymphatic system cancer	0.00192	0.00436	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.0019	0.00431	CcSEcCtD
Rifabutin—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00189	0.00429	CcSEcCtD
Rifabutin—Leukopenia—Fludarabine—lymphatic system cancer	0.00186	0.00423	CcSEcCtD
Rifabutin—Pruritus—Mechlorethamine—lymphatic system cancer	0.00185	0.00421	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00185	0.0042	CcSEcCtD
Rifabutin—Anorexia—Teniposide—lymphatic system cancer	0.00184	0.00418	CcSEcCtD
Rifabutin—Pancytopenia—Carmustine—lymphatic system cancer	0.00181	0.00412	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00181	0.00411	CcSEcCtD
Rifabutin—Convulsion—Fludarabine—lymphatic system cancer	0.0018	0.00409	CcSEcCtD
Rifabutin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00179	0.00407	CcSEcCtD
Rifabutin—Neutropenia—Carmustine—lymphatic system cancer	0.00178	0.00406	CcSEcCtD
Rifabutin—Arthralgia—Fludarabine—lymphatic system cancer	0.00177	0.00402	CcSEcCtD
Rifabutin—Myalgia—Fludarabine—lymphatic system cancer	0.00177	0.00402	CcSEcCtD
Rifabutin—Pancytopenia—Vincristine—lymphatic system cancer	0.00173	0.00393	CcSEcCtD
Rifabutin—Dyspnoea—Teniposide—lymphatic system cancer	0.00172	0.00391	CcSEcCtD
Rifabutin—Confusional state—Fludarabine—lymphatic system cancer	0.00171	0.00389	CcSEcCtD
Rifabutin—Neutropenia—Vincristine—lymphatic system cancer	0.0017	0.00387	CcSEcCtD
Rifabutin—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00168	0.00383	CcSEcCtD
Rifabutin—Decreased appetite—Teniposide—lymphatic system cancer	0.00168	0.00381	CcSEcCtD
Rifabutin—Vomiting—Mechlorethamine—lymphatic system cancer	0.00166	0.00378	CcSEcCtD
Rifabutin—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00166	0.00377	CcSEcCtD
Rifabutin—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00166	0.00377	CcSEcCtD
Rifabutin—Rash—Mechlorethamine—lymphatic system cancer	0.00165	0.00375	CcSEcCtD
Rifabutin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00165	0.00375	CcSEcCtD
Rifabutin—Anorexia—Fludarabine—lymphatic system cancer	0.00161	0.00367	CcSEcCtD
Rifabutin—Feeling abnormal—Teniposide—lymphatic system cancer	0.00159	0.00361	CcSEcCtD
Rifabutin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00158	0.00359	CcSEcCtD
Rifabutin—Skin discolouration—Methotrexate—lymphatic system cancer	0.00156	0.00354	CcSEcCtD
Rifabutin—Nausea—Mechlorethamine—lymphatic system cancer	0.00155	0.00353	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00154	0.00351	CcSEcCtD
Rifabutin—Jaundice—Mitoxantrone—lymphatic system cancer	0.00154	0.0035	CcSEcCtD
Rifabutin—Abdominal pain—Teniposide—lymphatic system cancer	0.00152	0.00347	CcSEcCtD
Rifabutin—Body temperature increased—Teniposide—lymphatic system cancer	0.00152	0.00347	CcSEcCtD
Rifabutin—Paraesthesia—Fludarabine—lymphatic system cancer	0.00152	0.00346	CcSEcCtD
Rifabutin—Dyspnoea—Fludarabine—lymphatic system cancer	0.00151	0.00344	CcSEcCtD
Rifabutin—Connective tissue disorder—Carmustine—lymphatic system cancer	0.0015	0.00341	CcSEcCtD
Rifabutin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00149	0.00339	CcSEcCtD
Rifabutin—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.00149	0.00338	CcSEcCtD
Rifabutin—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00147	0.00335	CcSEcCtD
Rifabutin—Decreased appetite—Fludarabine—lymphatic system cancer	0.00147	0.00335	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00146	0.00333	CcSEcCtD
Rifabutin—Pain—Fludarabine—lymphatic system cancer	0.00145	0.0033	CcSEcCtD
Rifabutin—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00143	0.00326	CcSEcCtD
Rifabutin—Eye disorder—Carmustine—lymphatic system cancer	0.00143	0.00324	CcSEcCtD
Rifabutin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00142	0.00323	CcSEcCtD
Rifabutin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00142	0.00323	CcSEcCtD
Rifabutin—Anaemia—Bleomycin—lymphatic system cancer	0.00141	0.0032	CcSEcCtD
Rifabutin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0014	0.00318	CcSEcCtD
Rifabutin—Asthenia—Teniposide—lymphatic system cancer	0.00138	0.00315	CcSEcCtD
Rifabutin—Pruritus—Teniposide—lymphatic system cancer	0.00136	0.0031	CcSEcCtD
Rifabutin—Leukopenia—Bleomycin—lymphatic system cancer	0.00136	0.0031	CcSEcCtD
Rifabutin—Body temperature increased—Fludarabine—lymphatic system cancer	0.00134	0.00305	CcSEcCtD
Rifabutin—Diarrhoea—Teniposide—lymphatic system cancer	0.00132	0.003	CcSEcCtD
Rifabutin—Chest pain—Bleomycin—lymphatic system cancer	0.0013	0.00295	CcSEcCtD
Rifabutin—Myalgia—Bleomycin—lymphatic system cancer	0.0013	0.00295	CcSEcCtD
Rifabutin—Confusional state—Bleomycin—lymphatic system cancer	0.00125	0.00285	CcSEcCtD
Rifabutin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00125	0.00284	CcSEcCtD
Rifabutin—Anaemia—Carmustine—lymphatic system cancer	0.00123	0.00279	CcSEcCtD
Rifabutin—Vomiting—Teniposide—lymphatic system cancer	0.00123	0.00279	CcSEcCtD
Rifabutin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00122	0.00277	CcSEcCtD
Rifabutin—Asthenia—Fludarabine—lymphatic system cancer	0.00122	0.00276	CcSEcCtD
Rifabutin—Rash—Teniposide—lymphatic system cancer	0.00121	0.00276	CcSEcCtD
Rifabutin—Dermatitis—Teniposide—lymphatic system cancer	0.00121	0.00276	CcSEcCtD
Rifabutin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00121	0.00275	CcSEcCtD
Rifabutin—Headache—Teniposide—lymphatic system cancer	0.00121	0.00275	CcSEcCtD
Rifabutin—Pruritus—Fludarabine—lymphatic system cancer	0.0012	0.00273	CcSEcCtD
Rifabutin—Leukopenia—Carmustine—lymphatic system cancer	0.00119	0.0027	CcSEcCtD
Rifabutin—Anorexia—Bleomycin—lymphatic system cancer	0.00118	0.00269	CcSEcCtD
Rifabutin—Anaemia—Vincristine—lymphatic system cancer	0.00117	0.00267	CcSEcCtD
Rifabutin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00116	0.00264	CcSEcCtD
Rifabutin—Convulsion—Carmustine—lymphatic system cancer	0.00115	0.00262	CcSEcCtD
Rifabutin—Nausea—Teniposide—lymphatic system cancer	0.00114	0.0026	CcSEcCtD
Rifabutin—Anaemia—Mitoxantrone—lymphatic system cancer	0.00114	0.0026	CcSEcCtD
Rifabutin—Leukopenia—Vincristine—lymphatic system cancer	0.00113	0.00258	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00113	0.00257	CcSEcCtD
Rifabutin—Myalgia—Carmustine—lymphatic system cancer	0.00113	0.00257	CcSEcCtD
Rifabutin—Chest pain—Carmustine—lymphatic system cancer	0.00113	0.00257	CcSEcCtD
Rifabutin—Paraesthesia—Bleomycin—lymphatic system cancer	0.00111	0.00254	CcSEcCtD
Rifabutin—Dyspnoea—Bleomycin—lymphatic system cancer	0.00111	0.00252	CcSEcCtD
Rifabutin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00111	0.00251	CcSEcCtD
Rifabutin—Convulsion—Vincristine—lymphatic system cancer	0.0011	0.0025	CcSEcCtD
Rifabutin—Confusional state—Carmustine—lymphatic system cancer	0.00109	0.00249	CcSEcCtD
Rifabutin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00108	0.00246	CcSEcCtD
Rifabutin—Myalgia—Vincristine—lymphatic system cancer	0.00108	0.00246	CcSEcCtD
Rifabutin—Vomiting—Fludarabine—lymphatic system cancer	0.00108	0.00245	CcSEcCtD
Rifabutin—Convulsion—Mitoxantrone—lymphatic system cancer	0.00107	0.00243	CcSEcCtD
Rifabutin—Rash—Fludarabine—lymphatic system cancer	0.00107	0.00243	CcSEcCtD
Rifabutin—Dermatitis—Fludarabine—lymphatic system cancer	0.00107	0.00243	CcSEcCtD
Rifabutin—Pain—Bleomycin—lymphatic system cancer	0.00106	0.00242	CcSEcCtD
Rifabutin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00106	0.00241	CcSEcCtD
Rifabutin—Headache—Fludarabine—lymphatic system cancer	0.00106	0.00241	CcSEcCtD
Rifabutin—Myalgia—Mitoxantrone—lymphatic system cancer	0.00105	0.00239	CcSEcCtD
Rifabutin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00105	0.00239	CcSEcCtD
Rifabutin—Chest pain—Mitoxantrone—lymphatic system cancer	0.00105	0.00239	CcSEcCtD
Rifabutin—Anorexia—Carmustine—lymphatic system cancer	0.00103	0.00235	CcSEcCtD
Rifabutin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00102	0.00233	CcSEcCtD
Rifabutin—Confusional state—Mitoxantrone—lymphatic system cancer	0.00102	0.00231	CcSEcCtD
Rifabutin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00101	0.0023	CcSEcCtD
Rifabutin—Nausea—Fludarabine—lymphatic system cancer	0.00101	0.00229	CcSEcCtD
Rifabutin—Shock—Mitoxantrone—lymphatic system cancer	0.000991	0.00226	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000987	0.00225	CcSEcCtD
Rifabutin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000987	0.00224	CcSEcCtD
Rifabutin—Anorexia—Vincristine—lymphatic system cancer	0.000986	0.00224	CcSEcCtD
Rifabutin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000982	0.00223	CcSEcCtD
Rifabutin—Insomnia—Carmustine—lymphatic system cancer	0.00098	0.00223	CcSEcCtD
Rifabutin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000979	0.00223	CcSEcCtD
Rifabutin—Paraesthesia—Carmustine—lymphatic system cancer	0.000973	0.00221	CcSEcCtD
Rifabutin—Dyspnoea—Carmustine—lymphatic system cancer	0.000966	0.0022	CcSEcCtD
Rifabutin—Anorexia—Mitoxantrone—lymphatic system cancer	0.00096	0.00219	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000943	0.00214	CcSEcCtD
Rifabutin—Decreased appetite—Carmustine—lymphatic system cancer	0.000942	0.00214	CcSEcCtD
Rifabutin—Insomnia—Vincristine—lymphatic system cancer	0.000936	0.00213	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000936	0.00213	CcSEcCtD
Rifabutin—Paraesthesia—Vincristine—lymphatic system cancer	0.000929	0.00211	CcSEcCtD
Rifabutin—Pain—Carmustine—lymphatic system cancer	0.000927	0.00211	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000918	0.00209	CcSEcCtD
Rifabutin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000915	0.00208	CcSEcCtD
Rifabutin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000905	0.00206	CcSEcCtD
Rifabutin—Decreased appetite—Vincristine—lymphatic system cancer	0.000899	0.00205	CcSEcCtD
Rifabutin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000898	0.00204	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000893	0.00203	CcSEcCtD
Rifabutin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000893	0.00203	CcSEcCtD
Rifabutin—Asthenia—Bleomycin—lymphatic system cancer	0.000891	0.00203	CcSEcCtD
Rifabutin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000887	0.00202	CcSEcCtD
Rifabutin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000886	0.00202	CcSEcCtD
Rifabutin—Pain—Vincristine—lymphatic system cancer	0.000885	0.00201	CcSEcCtD
Rifabutin—Pruritus—Bleomycin—lymphatic system cancer	0.000878	0.002	CcSEcCtD
Rifabutin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000876	0.00199	CcSEcCtD
Rifabutin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000874	0.00199	CcSEcCtD
Rifabutin—Pain—Mitoxantrone—lymphatic system cancer	0.000862	0.00196	CcSEcCtD
Rifabutin—Body temperature increased—Carmustine—lymphatic system cancer	0.000857	0.00195	CcSEcCtD
Rifabutin—Abdominal pain—Carmustine—lymphatic system cancer	0.000857	0.00195	CcSEcCtD
Rifabutin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000846	0.00193	CcSEcCtD
Rifabutin—Pancytopenia—Methotrexate—lymphatic system cancer	0.000838	0.00191	CcSEcCtD
Rifabutin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00083	0.00189	CcSEcCtD
Rifabutin—Neutropenia—Methotrexate—lymphatic system cancer	0.000826	0.00188	CcSEcCtD
Rifabutin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000824	0.00187	CcSEcCtD
Rifabutin—Abdominal pain—Vincristine—lymphatic system cancer	0.000818	0.00186	CcSEcCtD
Rifabutin—Body temperature increased—Vincristine—lymphatic system cancer	0.000818	0.00186	CcSEcCtD
Rifabutin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000799	0.00182	CcSEcCtD
Rifabutin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000797	0.00181	CcSEcCtD
Rifabutin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000797	0.00181	CcSEcCtD
Rifabutin—Vomiting—Bleomycin—lymphatic system cancer	0.000789	0.0018	CcSEcCtD
Rifabutin—Rash—Bleomycin—lymphatic system cancer	0.000783	0.00178	CcSEcCtD
Rifabutin—Dermatitis—Bleomycin—lymphatic system cancer	0.000782	0.00178	CcSEcCtD
Rifabutin—Asthenia—Carmustine—lymphatic system cancer	0.000778	0.00177	CcSEcCtD
Rifabutin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000762	0.00173	CcSEcCtD
Rifabutin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000744	0.00169	CcSEcCtD
Rifabutin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000742	0.00169	CcSEcCtD
Rifabutin—Asthenia—Vincristine—lymphatic system cancer	0.000742	0.00169	CcSEcCtD
Rifabutin—Diarrhoea—Carmustine—lymphatic system cancer	0.000742	0.00169	CcSEcCtD
Rifabutin—Nausea—Bleomycin—lymphatic system cancer	0.000738	0.00168	CcSEcCtD
Rifabutin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000735	0.00167	CcSEcCtD
Rifabutin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000723	0.00164	CcSEcCtD
Rifabutin—Diarrhoea—Vincristine—lymphatic system cancer	0.000708	0.00161	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—lymphatic system cancer	0.000707	0.00161	CcSEcCtD
Rifabutin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000689	0.00157	CcSEcCtD
Rifabutin—Vomiting—Carmustine—lymphatic system cancer	0.000689	0.00157	CcSEcCtD
Rifabutin—Rash—Carmustine—lymphatic system cancer	0.000683	0.00155	CcSEcCtD
Rifabutin—Dermatitis—Carmustine—lymphatic system cancer	0.000683	0.00155	CcSEcCtD
Rifabutin—Headache—Carmustine—lymphatic system cancer	0.000679	0.00154	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—lymphatic system cancer	0.00066	0.0015	CcSEcCtD
Rifabutin—Vomiting—Vincristine—lymphatic system cancer	0.000658	0.0015	CcSEcCtD
Rifabutin—Rash—Vincristine—lymphatic system cancer	0.000652	0.00148	CcSEcCtD
Rifabutin—Dermatitis—Vincristine—lymphatic system cancer	0.000652	0.00148	CcSEcCtD
Rifabutin—Headache—Vincristine—lymphatic system cancer	0.000648	0.00147	CcSEcCtD
Rifabutin—Nausea—Carmustine—lymphatic system cancer	0.000644	0.00146	CcSEcCtD
Rifabutin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000641	0.00146	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—lymphatic system cancer	0.000638	0.00145	CcSEcCtD
Rifabutin—Rash—Mitoxantrone—lymphatic system cancer	0.000635	0.00145	CcSEcCtD
Rifabutin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000635	0.00144	CcSEcCtD
Rifabutin—Headache—Mitoxantrone—lymphatic system cancer	0.000631	0.00144	CcSEcCtD
Rifabutin—Nausea—Vincristine—lymphatic system cancer	0.000615	0.0014	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000602	0.00137	CcSEcCtD
Rifabutin—Nausea—Mitoxantrone—lymphatic system cancer	0.000599	0.00136	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—lymphatic system cancer	0.000569	0.00129	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—lymphatic system cancer	0.000551	0.00125	CcSEcCtD
Rifabutin—Convulsion—Methotrexate—lymphatic system cancer	0.000533	0.00121	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—lymphatic system cancer	0.000524	0.00119	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—lymphatic system cancer	0.000524	0.00119	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—lymphatic system cancer	0.000524	0.00119	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00052	0.00118	CcSEcCtD
Rifabutin—Confusional state—Methotrexate—lymphatic system cancer	0.000506	0.00115	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000492	0.00112	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—lymphatic system cancer	0.000488	0.00111	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—lymphatic system cancer	0.000479	0.00109	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000457	0.00104	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—lymphatic system cancer	0.000454	0.00103	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000451	0.00103	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000448	0.00102	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000442	0.00101	CcSEcCtD
Rifabutin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000436	0.000993	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000433	0.000986	CcSEcCtD
Rifabutin—Pain—Methotrexate—lymphatic system cancer	0.000429	0.000977	CcSEcCtD
Rifabutin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000414	0.000941	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000411	0.000934	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000397	0.000903	CcSEcCtD
Rifabutin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000397	0.000903	CcSEcCtD
Rifabutin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00037	0.000842	CcSEcCtD
Rifabutin—Asthenia—Methotrexate—lymphatic system cancer	0.00036	0.00082	CcSEcCtD
Rifabutin—Pruritus—Methotrexate—lymphatic system cancer	0.000355	0.000808	CcSEcCtD
Rifabutin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000343	0.000782	CcSEcCtD
Rifabutin—Vomiting—Methotrexate—lymphatic system cancer	0.000319	0.000726	CcSEcCtD
Rifabutin—Rash—Methotrexate—lymphatic system cancer	0.000317	0.00072	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—lymphatic system cancer	0.000316	0.00072	CcSEcCtD
Rifabutin—Headache—Methotrexate—lymphatic system cancer	0.000315	0.000716	CcSEcCtD
Rifabutin—Nausea—Methotrexate—lymphatic system cancer	0.000298	0.000678	CcSEcCtD
